טוען...
5α-reductase Inhibitors and Risk of High-grade or Lethal Prostate Cancer
IMPORTANCE: 5α-reductase inhibitors (5ARIs) are widely used for benign prostatic hyperplasia despite controversy regarding potential risk of high-grade prostate cancer with use. Furthermore, the effect of 5ARIs on progression and prostate cancer death remains unclear. OBJECTIVE: To determine the ass...
שמור ב:
| Main Authors: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4122627/ https://ncbi.nlm.nih.gov/pubmed/24887392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2014.1600 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|